Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Total Debt / (EBITDA-CAPEX)

Aquestive Therapeutics Inc Total Debt / (EBITDA-CAPEX) Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Total Debt / (EBITDA-CAPEX) from 2017 to 2018.
  • Aquestive Therapeutics Inc Total Debt / (EBITDA-CAPEX) for the quarter ending March 03, 2018 was $2m
  • Aquestive Therapeutics Inc Total Debt / (EBITDA-CAPEX) for the last 12 months ending March 03, 2018 was $7m
  • Aquestive Therapeutics Inc Annual Total Debt / (EBITDA-CAPEX) for 2017 was $26m a 31.98% increase of 8m from 2016
  • Aquestive Therapeutics Inc Annual Total Debt / (EBITDA-CAPEX) for 2016 was $18m
Other Ratios Metrics:
  • Aquestive Therapeutics Inc Total Debt / Capital for the quarter ending December 12, 2018 was $82m a -136.67% decrease of -113m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Debt / Equity for the quarter ending December 12, 2018 was $468m
View Chart On Koyfin

Quarterly AQST Total Debt / (EBITDA-CAPEX) Data

03/2018$2m
03/2017$9m

Annual AQST Total Debt / (EBITDA-CAPEX) Data

2017$26m
2016$18m